MedPath

Chenodeoxycholic acid

Generic Name
Chenodeoxycholic acid
Brand Names
Chenodal, Chenodeoxycholic acid Leadiant (previously known as Chenodeoxycholic acid sigma-tau)
Drug Type
Small Molecule
Chemical Formula
C24H40O4
CAS Number
474-25-9
Unique Ingredient Identifier
0GEI24LG0J

Overview

Chenodeoxycholic acid (or Chenodiol) is an epimer of ursodeoxycholic acid (DB01586). Chenodeoxycholic acid is a bile acid naturally found in the body. It works by dissolving the cholesterol that makes gallstones and inhibiting production of cholesterol in the liver and absorption in the intestines, which helps to decrease the formation of gallstones. It can also reduce the amount of other bile acids that can be harmful to liver cells when levels are elevated.

Background

Chenodeoxycholic acid (or Chenodiol) is an epimer of ursodeoxycholic acid (DB01586). Chenodeoxycholic acid is a bile acid naturally found in the body. It works by dissolving the cholesterol that makes gallstones and inhibiting production of cholesterol in the liver and absorption in the intestines, which helps to decrease the formation of gallstones. It can also reduce the amount of other bile acids that can be harmful to liver cells when levels are elevated.

Indication

Chenodiol is indicated for patients with radiolucent stones in well-opacifying gallbladders, in whom selective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age. Chenodiol will not dissolve calcified (radiopaque) or radiolucent bile pigment stones.

Associated Conditions

  • Radiolucent Cholesterol gallstones

FDA Approved Products

Chenodiol
Manufacturer:Nexgen Pharma, Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2019/09/06
NDC:0722-7121
Chenodiol
Manufacturer:LGM PHARMA SOLUTIONS, LLC
Route:ORAL
Strength:250 mg in 1 1
Approved: 2023/04/28
NDC:79739-7121
Chenodal
Manufacturer:Manchester Pharmaceuticals Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2010/01/07
NDC:45043-876
Chenodal
Manufacturer:Travere Therapeutics
Route:ORAL
Strength:250 mg in 1 1
Approved: 2023/07/07
NDC:68974-876

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath